fda bpc-157 category 2 bulk drug substance list The peptide comeback narrative has a problem. staff said no to all seven. Earlier this year, some peptides came off FDA's list, the bucket for substances FDA BPC-157 Canada Research Guide 2026:
BPC 157 Canada Research Guide 2026: Sourcing, and Compliance FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog You may have heard buzz about 14 peptides potentially returning to legal compounding. Here's what we know: HHS Secretary RFK Jr. stated his intention to move these peptides from FDA Category 2 BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

